Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

iNtRON Biotechnology Inc (048530)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
20,450 +250    +1.24%
20:40:00 - Delayed Data. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7048530000 
  • Volume: 661,741
  • Bid/Ask: 20,450 / 20,500
  • Day's Range: 20,200 - 22,200
iNtRON Biotechnology 20,450 +250 +1.24%

048530 Cash Flow Statement

 
Featured here, the Cash Flow Statement for iNtRON Biotechnology Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
Collapse All
Period Ending: 2021
30/09
 2021
30/06
 2021
31/03
 2020
31/12
Period Length: 9 Months 6 Months 3 Months 12 Months
Net Income/Starting Line 7177.09 4882.44 1365.75 14947.97
Cash From Operating Activities 9406.74 7389.75 5249.26 7131.02
Depreciation/Depletion 987.62 640.92 314.5 1397.24
Amortization 148.73 95.2 67.57 171.88
Deferred Taxes - - - -
Non-Cash Items 486.76 864.72 676.39 20.64
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 253.69 237.92 13.75 -134.45
Cash Interest Paid 9.22 6.46 3.49 23.97
Changes in Working Capital 606.54 906.48 2825.06 -9406.71
Cash From Investing Activities -33144.22 -2645.96 -117.16 2356.28
Capital Expenditures -2311.71 -1749.19 -1312.04 -6070.45
Other Investing Cash Flow Items, Total -30832.5 -896.78 1194.88 8426.72
Cash From Financing Activities 39801.65 -126.58 34.79 -2066.15
Financing Cash Flow Items -0.01 -0.01 97.82 -56.64
Total Cash Dividends Paid - - - -
Issuance (Retirement) of Stock, Net - - - -
Issuance (Retirement) of Debt, Net 39801.66 -126.57 -63.02 -2009.5
Foreign Exchange Effects 542.7 61.94 50.28 -907
Net Change in Cash 16606.87 4679.16 5217.17 6514.16
Beginning Cash Balance - - - -
Ending Cash Balance - - - -
Free Cash Flow - - - -
Free Cash Flow Growth - - - -
Free Cash Flow Yield - - - -
* In Millions of KRW (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

048530 Comments

Write your thoughts about iNtRON Biotechnology Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email